92 related articles for article (PubMed ID: 1707983)
1. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
[TBL] [Abstract][Full Text] [Related]
2. Antigenic sites on foot-and-mouth disease virus type A10.
Thomas AA; Woortmeijer RJ; Puijk W; Barteling SJ
J Virol; 1988 Aug; 62(8):2782-9. PubMed ID: 2455819
[TBL] [Abstract][Full Text] [Related]
3. Conserved antigen structures and antibody-driven variations on foot-and-mouth disease virus serotype A revealed by bovine neutralizing monoclonal antibodies.
Li K; He Y; Wang L; Li P; Bao H; Huang S; Zhou S; Zhu G; Song Y; Li Y; Wang S; Zhang Q; Sun P; Bai X; Zhao Z; Lou Z; Cao Y; Lu Z; Liu Z
PLoS Pathog; 2023 Nov; 19(11):e1011811. PubMed ID: 37983290
[TBL] [Abstract][Full Text] [Related]
4. B and T Cell Epitopes of the Incursionary Foot-and-Mouth Disease Virus Serotype SAT2 for Vaccine Development.
Li Q; Wubshet AK; Wang Y; Heath L; Zhang J
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992505
[TBL] [Abstract][Full Text] [Related]
5. Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibility.
Harmsen MM; Li H; Sun S; van der Poel WHM; Dekker A
Front Vet Sci; 2022; 9():1040802. PubMed ID: 36699337
[TBL] [Abstract][Full Text] [Related]
6. Establishing an In Vitro System to Assess How Specific Antibodies Drive the Evolution of Foot-and-Mouth Disease Virus.
King DJ; Freimanis G; Neil C; Shaw A; Tuthill TJ; Laing E; King DP; Lasecka-Dykes L
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016442
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary and Ecological Drivers Shape the Emergence and Extinction of Foot-and-Mouth Disease Virus Lineages.
Di Nardo A; Ferretti L; Wadsworth J; Mioulet V; Gelman B; Karniely S; Scherbakov A; Ziay G; Özyörük F; Parlak Ü; Tuncer-Göktuna P; Hassanzadeh R; Khalaj M; Dastoor SM; Abdollahi D; Khan EU; Afzal M; Hussain M; Knowles NJ; King DP
Mol Biol Evol; 2021 Sep; 38(10):4346-4361. PubMed ID: 34115138
[TBL] [Abstract][Full Text] [Related]
8. The HSP70-fused foot-and-mouth disease epitope elicits cellular and humoral immunity and drives broad-spectrum protective efficacy.
Jo H; Kim BY; Park SH; Kim HM; Shin SH; Hwang SY; Kim SM; Kim B; Park JH; Lee MJ
NPJ Vaccines; 2021 Mar; 6(1):42. PubMed ID: 33772029
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus.
Yang B; Zhang X; Zhang D; Hou J; Xu G; Sheng C; Choudhury SM; Zhu Z; Li D; Zhang K; Zheng H; Liu X
Pathogens; 2020 Sep; 9(9):. PubMed ID: 32899635
[TBL] [Abstract][Full Text] [Related]
10. Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.
Yang M; Xu W; Bittner H; Horsington J; Vosloo W; Goolia M; Lusansky D; Nfon C
Virol J; 2016 Nov; 13(1):195. PubMed ID: 27894355
[TBL] [Abstract][Full Text] [Related]
11. Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis.
Bari FD; Parida S; Asfor AS; Haydon DT; Reeve R; Paton DJ; Mahapatra M
J Gen Virol; 2015 May; 96(Pt 5):1033-1041. PubMed ID: 25614587
[TBL] [Abstract][Full Text] [Related]
12. Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli.
Farshadpour F; Taherkhani R; Makvandi M; Rajabi Memari H; Samarbafzadeh AR
Jundishapur J Microbiol; 2014 Jul; 7(7):e11261. PubMed ID: 25368796
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections.
Kotani O; Iwata-Yoshikawa N; Suzuki T; Sato Y; Nakajima N; Koike S; Iwasaki T; Sata T; Yamashita T; Minagawa H; Taguchi F; Hasegawa H; Shimizu H; Nagata N
Neuropathology; 2015 Apr; 35(2):107-21. PubMed ID: 25263613
[TBL] [Abstract][Full Text] [Related]
14. Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains.
Bari FD; Parida S; Tekleghiorghis T; Dekker A; Sangula A; Reeve R; Haydon DT; Paton DJ; Mahapatra M
Vaccine; 2014 Oct; 32(44):5794-800. PubMed ID: 25171846
[TBL] [Abstract][Full Text] [Related]
15. Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus.
Taherkhani R; Makvandi M; Farshadpour F
Ann Lab Med; 2014 Mar; 34(2):118-26. PubMed ID: 24624347
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa.
Chitray M; de Beer TA; Vosloo W; Maree FF
Arch Virol; 2014 May; 159(5):947-61. PubMed ID: 24221247
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East.
Upadhyaya S; Ayelet G; Paul G; King DP; Paton DJ; Mahapatra M
Vaccine; 2014 Jan; 32(5):631-8. PubMed ID: 24035435
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.
Borley DW; Mahapatra M; Paton DJ; Esnouf RM; Stuart DI; Fry EE
PLoS One; 2013; 8(5):e61122. PubMed ID: 23667434
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
